nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanabenz—Vomiting—Azathioprine—multiple sclerosis	0.00106	0.00113	CcSEcCtD
Guanabenz—Arthralgia—Methylprednisolone—multiple sclerosis	0.00106	0.00113	CcSEcCtD
Guanabenz—Myalgia—Methylprednisolone—multiple sclerosis	0.00106	0.00113	CcSEcCtD
Guanabenz—Eye disorder—Prednisone—multiple sclerosis	0.00105	0.00113	CcSEcCtD
Guanabenz—Anxiety—Methylprednisolone—multiple sclerosis	0.00105	0.00113	CcSEcCtD
Guanabenz—Infestation NOS—Methotrexate—multiple sclerosis	0.00105	0.00112	CcSEcCtD
Guanabenz—Infestation—Methotrexate—multiple sclerosis	0.00105	0.00112	CcSEcCtD
Guanabenz—Rash—Azathioprine—multiple sclerosis	0.00105	0.00112	CcSEcCtD
Guanabenz—Dermatitis—Azathioprine—multiple sclerosis	0.00105	0.00112	CcSEcCtD
Guanabenz—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.00105	0.00112	CcSEcCtD
Guanabenz—Ill-defined disorder—Betamethasone—multiple sclerosis	0.00105	0.00112	CcSEcCtD
Guanabenz—Discomfort—Triamcinolone—multiple sclerosis	0.00105	0.00112	CcSEcCtD
Guanabenz—Discomfort—Methylprednisolone—multiple sclerosis	0.00104	0.00112	CcSEcCtD
Guanabenz—Headache—Azathioprine—multiple sclerosis	0.00104	0.00112	CcSEcCtD
Guanabenz—Dry mouth—Triamcinolone—multiple sclerosis	0.00104	0.00111	CcSEcCtD
Guanabenz—Angioedema—Dexamethasone—multiple sclerosis	0.00103	0.0011	CcSEcCtD
Guanabenz—Angioedema—Betamethasone—multiple sclerosis	0.00103	0.0011	CcSEcCtD
Guanabenz—Confusional state—Methylprednisolone—multiple sclerosis	0.00102	0.00109	CcSEcCtD
Guanabenz—Immune system disorder—Prednisone—multiple sclerosis	0.00102	0.00109	CcSEcCtD
Guanabenz—Malaise—Dexamethasone—multiple sclerosis	0.00102	0.00109	CcSEcCtD
Guanabenz—Malaise—Betamethasone—multiple sclerosis	0.00102	0.00109	CcSEcCtD
Guanabenz—Oedema—Triamcinolone—multiple sclerosis	0.00101	0.00109	CcSEcCtD
Guanabenz—Syncope—Dexamethasone—multiple sclerosis	0.00101	0.00108	CcSEcCtD
Guanabenz—Syncope—Betamethasone—multiple sclerosis	0.00101	0.00108	CcSEcCtD
Guanabenz—Infection—Triamcinolone—multiple sclerosis	0.00101	0.00108	CcSEcCtD
Guanabenz—Infection—Methylprednisolone—multiple sclerosis	0.00101	0.00108	CcSEcCtD
Guanabenz—Shock—Triamcinolone—multiple sclerosis	0.000998	0.00107	CcSEcCtD
Guanabenz—Shock—Methylprednisolone—multiple sclerosis	0.000996	0.00107	CcSEcCtD
Guanabenz—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000993	0.00106	CcSEcCtD
Guanabenz—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000992	0.00106	CcSEcCtD
Guanabenz—Loss of consciousness—Betamethasone—multiple sclerosis	0.000992	0.00106	CcSEcCtD
Guanabenz—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000991	0.00106	CcSEcCtD
Guanabenz—Paraesthesia—Prednisolone—multiple sclerosis	0.000991	0.00106	CcSEcCtD
Guanabenz—Tachycardia—Triamcinolone—multiple sclerosis	0.00099	0.00106	CcSEcCtD
Guanabenz—Nausea—Azathioprine—multiple sclerosis	0.000988	0.00106	CcSEcCtD
Guanabenz—Tachycardia—Methylprednisolone—multiple sclerosis	0.000988	0.00106	CcSEcCtD
Guanabenz—Skin disorder—Methylprednisolone—multiple sclerosis	0.000983	0.00105	CcSEcCtD
Guanabenz—Malnutrition—Prednisone—multiple sclerosis	0.000982	0.00105	CcSEcCtD
Guanabenz—Erythema—Prednisone—multiple sclerosis	0.000982	0.00105	CcSEcCtD
Guanabenz—Hypertension—Betamethasone—multiple sclerosis	0.000974	0.00104	CcSEcCtD
Guanabenz—Hypertension—Dexamethasone—multiple sclerosis	0.000974	0.00104	CcSEcCtD
Guanabenz—Asthenia—Mitoxantrone—multiple sclerosis	0.000965	0.00103	CcSEcCtD
Guanabenz—Myalgia—Dexamethasone—multiple sclerosis	0.00096	0.00103	CcSEcCtD
Guanabenz—Myalgia—Betamethasone—multiple sclerosis	0.00096	0.00103	CcSEcCtD
Guanabenz—Anxiety—Betamethasone—multiple sclerosis	0.000957	0.00102	CcSEcCtD
Guanabenz—Anxiety—Dexamethasone—multiple sclerosis	0.000957	0.00102	CcSEcCtD
Guanabenz—Discomfort—Betamethasone—multiple sclerosis	0.000949	0.00102	CcSEcCtD
Guanabenz—Discomfort—Dexamethasone—multiple sclerosis	0.000949	0.00102	CcSEcCtD
Guanabenz—Haemoglobin—Methotrexate—multiple sclerosis	0.000948	0.00101	CcSEcCtD
Guanabenz—Hypotension—Methylprednisolone—multiple sclerosis	0.000946	0.00101	CcSEcCtD
Guanabenz—Pain—Prednisolone—multiple sclerosis	0.000944	0.00101	CcSEcCtD
Guanabenz—Haemorrhage—Methotrexate—multiple sclerosis	0.000943	0.00101	CcSEcCtD
Guanabenz—Vision blurred—Prednisone—multiple sclerosis	0.000926	0.000991	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000924	0.000989	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000922	0.000987	CcSEcCtD
Guanabenz—Oedema—Betamethasone—multiple sclerosis	0.000921	0.000985	CcSEcCtD
Guanabenz—Oedema—Dexamethasone—multiple sclerosis	0.000921	0.000985	CcSEcCtD
Guanabenz—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00092	0.000985	CcSEcCtD
Guanabenz—Infection—Betamethasone—multiple sclerosis	0.000915	0.000979	CcSEcCtD
Guanabenz—Infection—Dexamethasone—multiple sclerosis	0.000915	0.000979	CcSEcCtD
Guanabenz—Ill-defined disorder—Prednisone—multiple sclerosis	0.000912	0.000975	CcSEcCtD
Guanabenz—Paraesthesia—Triamcinolone—multiple sclerosis	0.000911	0.000975	CcSEcCtD
Guanabenz—Feeling abnormal—Prednisolone—multiple sclerosis	0.000909	0.000973	CcSEcCtD
Guanabenz—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000909	0.000973	CcSEcCtD
Guanabenz—Anaemia—Prednisone—multiple sclerosis	0.000908	0.000972	CcSEcCtD
Guanabenz—Shock—Dexamethasone—multiple sclerosis	0.000906	0.000969	CcSEcCtD
Guanabenz—Shock—Betamethasone—multiple sclerosis	0.000906	0.000969	CcSEcCtD
Guanabenz—Dyspnoea—Triamcinolone—multiple sclerosis	0.000905	0.000968	CcSEcCtD
Guanabenz—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000903	0.000966	CcSEcCtD
Guanabenz—Nervous system disorder—Betamethasone—multiple sclerosis	0.000903	0.000966	CcSEcCtD
Guanabenz—Agitation—Prednisone—multiple sclerosis	0.000903	0.000966	CcSEcCtD
Guanabenz—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000901	0.000964	CcSEcCtD
Guanabenz—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000901	0.000964	CcSEcCtD
Guanabenz—Tachycardia—Betamethasone—multiple sclerosis	0.000899	0.000961	CcSEcCtD
Guanabenz—Tachycardia—Dexamethasone—multiple sclerosis	0.000899	0.000961	CcSEcCtD
Guanabenz—Angioedema—Prednisone—multiple sclerosis	0.000898	0.00096	CcSEcCtD
Guanabenz—Dyspepsia—Triamcinolone—multiple sclerosis	0.000893	0.000956	CcSEcCtD
Guanabenz—Erythema multiforme—Methotrexate—multiple sclerosis	0.000892	0.000954	CcSEcCtD
Guanabenz—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000891	0.000954	CcSEcCtD
Guanabenz—Malaise—Prednisone—multiple sclerosis	0.000886	0.000948	CcSEcCtD
Guanabenz—Eye disorder—Methotrexate—multiple sclerosis	0.000881	0.000943	CcSEcCtD
Guanabenz—Syncope—Prednisone—multiple sclerosis	0.000881	0.000943	CcSEcCtD
Guanabenz—Tinnitus—Methotrexate—multiple sclerosis	0.000879	0.000941	CcSEcCtD
Guanabenz—Anorexia—Dexamethasone—multiple sclerosis	0.000878	0.000939	CcSEcCtD
Guanabenz—Anorexia—Betamethasone—multiple sclerosis	0.000878	0.000939	CcSEcCtD
Guanabenz—Urticaria—Prednisolone—multiple sclerosis	0.000877	0.000938	CcSEcCtD
Guanabenz—Fatigue—Triamcinolone—multiple sclerosis	0.000875	0.000936	CcSEcCtD
Guanabenz—Fatigue—Methylprednisolone—multiple sclerosis	0.000873	0.000934	CcSEcCtD
Guanabenz—Pain—Triamcinolone—multiple sclerosis	0.000868	0.000928	CcSEcCtD
Guanabenz—Loss of consciousness—Prednisone—multiple sclerosis	0.000864	0.000924	CcSEcCtD
Guanabenz—Hypotension—Dexamethasone—multiple sclerosis	0.00086	0.00092	CcSEcCtD
Guanabenz—Hypotension—Betamethasone—multiple sclerosis	0.00086	0.00092	CcSEcCtD
Guanabenz—Vomiting—Mitoxantrone—multiple sclerosis	0.000855	0.000915	CcSEcCtD
Guanabenz—Immune system disorder—Methotrexate—multiple sclerosis	0.000852	0.000911	CcSEcCtD
Guanabenz—Mediastinal disorder—Methotrexate—multiple sclerosis	0.00085	0.000909	CcSEcCtD
Guanabenz—Hypertension—Prednisone—multiple sclerosis	0.000848	0.000907	CcSEcCtD
Guanabenz—Rash—Mitoxantrone—multiple sclerosis	0.000848	0.000907	CcSEcCtD
Guanabenz—Dermatitis—Mitoxantrone—multiple sclerosis	0.000847	0.000906	CcSEcCtD
Guanabenz—Chills—Methotrexate—multiple sclerosis	0.000846	0.000905	CcSEcCtD
Guanabenz—Headache—Mitoxantrone—multiple sclerosis	0.000843	0.000901	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000839	0.000897	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000839	0.000897	CcSEcCtD
Guanabenz—Arthralgia—Prednisone—multiple sclerosis	0.000836	0.000895	CcSEcCtD
Guanabenz—Myalgia—Prednisone—multiple sclerosis	0.000836	0.000895	CcSEcCtD
Guanabenz—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000836	0.000895	CcSEcCtD
Guanabenz—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000834	0.000893	CcSEcCtD
Guanabenz—Anxiety—Prednisone—multiple sclerosis	0.000834	0.000892	CcSEcCtD
Guanabenz—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000828	0.000886	CcSEcCtD
Guanabenz—Paraesthesia—Dexamethasone—multiple sclerosis	0.000827	0.000885	CcSEcCtD
Guanabenz—Paraesthesia—Betamethasone—multiple sclerosis	0.000827	0.000885	CcSEcCtD
Guanabenz—Discomfort—Prednisone—multiple sclerosis	0.000826	0.000884	CcSEcCtD
Guanabenz—Malnutrition—Methotrexate—multiple sclerosis	0.000821	0.000878	CcSEcCtD
Guanabenz—Erythema—Methotrexate—multiple sclerosis	0.000821	0.000878	CcSEcCtD
Guanabenz—Hypersensitivity—Prednisolone—multiple sclerosis	0.000813	0.00087	CcSEcCtD
Guanabenz—Dyspepsia—Dexamethasone—multiple sclerosis	0.00081	0.000867	CcSEcCtD
Guanabenz—Dyspepsia—Betamethasone—multiple sclerosis	0.00081	0.000867	CcSEcCtD
Guanabenz—Urticaria—Triamcinolone—multiple sclerosis	0.000806	0.000862	CcSEcCtD
Guanabenz—Urticaria—Methylprednisolone—multiple sclerosis	0.000804	0.000861	CcSEcCtD
Guanabenz—Body temperature increased—Triamcinolone—multiple sclerosis	0.000802	0.000858	CcSEcCtD
Guanabenz—Oedema—Prednisone—multiple sclerosis	0.000802	0.000858	CcSEcCtD
Guanabenz—Abdominal pain—Methylprednisolone—multiple sclerosis	0.0008	0.000856	CcSEcCtD
Guanabenz—Decreased appetite—Betamethasone—multiple sclerosis	0.0008	0.000856	CcSEcCtD
Guanabenz—Decreased appetite—Dexamethasone—multiple sclerosis	0.0008	0.000856	CcSEcCtD
Guanabenz—Nausea—Mitoxantrone—multiple sclerosis	0.000799	0.000855	CcSEcCtD
Guanabenz—Infection—Prednisone—multiple sclerosis	0.000797	0.000852	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000795	0.00085	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000795	0.00085	CcSEcCtD
Guanabenz—Back pain—Methotrexate—multiple sclerosis	0.000794	0.00085	CcSEcCtD
Guanabenz—Fatigue—Dexamethasone—multiple sclerosis	0.000794	0.000849	CcSEcCtD
Guanabenz—Fatigue—Betamethasone—multiple sclerosis	0.000794	0.000849	CcSEcCtD
Guanabenz—Shock—Prednisone—multiple sclerosis	0.000789	0.000844	CcSEcCtD
Guanabenz—Pain—Dexamethasone—multiple sclerosis	0.000787	0.000842	CcSEcCtD
Guanabenz—Pain—Betamethasone—multiple sclerosis	0.000787	0.000842	CcSEcCtD
Guanabenz—Nervous system disorder—Prednisone—multiple sclerosis	0.000786	0.000841	CcSEcCtD
Guanabenz—Tachycardia—Prednisone—multiple sclerosis	0.000783	0.000837	CcSEcCtD
Guanabenz—Skin disorder—Prednisone—multiple sclerosis	0.000779	0.000833	CcSEcCtD
Guanabenz—Vision blurred—Methotrexate—multiple sclerosis	0.000774	0.000828	CcSEcCtD
Guanabenz—Anorexia—Prednisone—multiple sclerosis	0.000764	0.000818	CcSEcCtD
Guanabenz—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000762	0.000815	CcSEcCtD
Guanabenz—Anaemia—Methotrexate—multiple sclerosis	0.000759	0.000812	CcSEcCtD
Guanabenz—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000759	0.000812	CcSEcCtD
Guanabenz—Feeling abnormal—Betamethasone—multiple sclerosis	0.000759	0.000812	CcSEcCtD
Guanabenz—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000753	0.000806	CcSEcCtD
Guanabenz—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000753	0.000806	CcSEcCtD
Guanabenz—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000748	0.0008	CcSEcCtD
Guanabenz—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000746	0.000798	CcSEcCtD
Guanabenz—Malaise—Methotrexate—multiple sclerosis	0.00074	0.000792	CcSEcCtD
Guanabenz—Leukopenia—Methotrexate—multiple sclerosis	0.000735	0.000786	CcSEcCtD
Guanabenz—Urticaria—Dexamethasone—multiple sclerosis	0.000731	0.000783	CcSEcCtD
Guanabenz—Urticaria—Betamethasone—multiple sclerosis	0.000731	0.000783	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000731	0.000782	CcSEcCtD
Guanabenz—Dizziness—Prednisolone—multiple sclerosis	0.00073	0.000781	CcSEcCtD
Guanabenz—Asthenia—Triamcinolone—multiple sclerosis	0.000728	0.000779	CcSEcCtD
Guanabenz—Abdominal pain—Betamethasone—multiple sclerosis	0.000728	0.000779	CcSEcCtD
Guanabenz—Body temperature increased—Dexamethasone—multiple sclerosis	0.000728	0.000779	CcSEcCtD
Guanabenz—Abdominal pain—Dexamethasone—multiple sclerosis	0.000728	0.000779	CcSEcCtD
Guanabenz—Body temperature increased—Betamethasone—multiple sclerosis	0.000728	0.000779	CcSEcCtD
Guanabenz—Asthenia—Methylprednisolone—multiple sclerosis	0.000726	0.000777	CcSEcCtD
Guanabenz—Paraesthesia—Prednisone—multiple sclerosis	0.00072	0.00077	CcSEcCtD
Guanabenz—Pruritus—Triamcinolone—multiple sclerosis	0.000718	0.000768	CcSEcCtD
Guanabenz—Cough—Methotrexate—multiple sclerosis	0.000716	0.000767	CcSEcCtD
Guanabenz—Pruritus—Methylprednisolone—multiple sclerosis	0.000716	0.000766	CcSEcCtD
Guanabenz—Dyspepsia—Prednisone—multiple sclerosis	0.000706	0.000755	CcSEcCtD
Guanabenz—Arthralgia—Methotrexate—multiple sclerosis	0.000699	0.000748	CcSEcCtD
Guanabenz—Chest pain—Methotrexate—multiple sclerosis	0.000699	0.000748	CcSEcCtD
Guanabenz—Myalgia—Methotrexate—multiple sclerosis	0.000699	0.000748	CcSEcCtD
Guanabenz—Decreased appetite—Prednisone—multiple sclerosis	0.000697	0.000746	CcSEcCtD
Guanabenz—Rash—Prednisolone—multiple sclerosis	0.000696	0.000744	CcSEcCtD
Guanabenz—Dermatitis—Prednisolone—multiple sclerosis	0.000695	0.000744	CcSEcCtD
Guanabenz—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000693	0.000741	CcSEcCtD
Guanabenz—Fatigue—Prednisone—multiple sclerosis	0.000691	0.00074	CcSEcCtD
Guanabenz—Headache—Prednisolone—multiple sclerosis	0.000691	0.00074	CcSEcCtD
Guanabenz—Discomfort—Methotrexate—multiple sclerosis	0.000691	0.000739	CcSEcCtD
Guanabenz—Constipation—Prednisone—multiple sclerosis	0.000686	0.000734	CcSEcCtD
Guanabenz—Confusional state—Methotrexate—multiple sclerosis	0.000676	0.000723	CcSEcCtD
Guanabenz—Dizziness—Triamcinolone—multiple sclerosis	0.000671	0.000718	CcSEcCtD
Guanabenz—Dizziness—Methylprednisolone—multiple sclerosis	0.00067	0.000716	CcSEcCtD
Guanabenz—Infection—Methotrexate—multiple sclerosis	0.000666	0.000712	CcSEcCtD
Guanabenz—Feeling abnormal—Prednisone—multiple sclerosis	0.000661	0.000707	CcSEcCtD
Guanabenz—Asthenia—Dexamethasone—multiple sclerosis	0.000661	0.000707	CcSEcCtD
Guanabenz—Asthenia—Betamethasone—multiple sclerosis	0.000661	0.000707	CcSEcCtD
Guanabenz—Nervous system disorder—Methotrexate—multiple sclerosis	0.000657	0.000703	CcSEcCtD
Guanabenz—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000656	0.000702	CcSEcCtD
Guanabenz—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000656	0.000701	CcSEcCtD
Guanabenz—Nausea—Prednisolone—multiple sclerosis	0.000655	0.000701	CcSEcCtD
Guanabenz—Pruritus—Dexamethasone—multiple sclerosis	0.000651	0.000697	CcSEcCtD
Guanabenz—Pruritus—Betamethasone—multiple sclerosis	0.000651	0.000697	CcSEcCtD
Guanabenz—Skin disorder—Methotrexate—multiple sclerosis	0.000651	0.000696	CcSEcCtD
Guanabenz—Vomiting—Triamcinolone—multiple sclerosis	0.000645	0.00069	CcSEcCtD
Guanabenz—Vomiting—Methylprednisolone—multiple sclerosis	0.000644	0.000689	CcSEcCtD
Guanabenz—Rash—Triamcinolone—multiple sclerosis	0.00064	0.000685	CcSEcCtD
Guanabenz—Dermatitis—Triamcinolone—multiple sclerosis	0.000639	0.000684	CcSEcCtD
Guanabenz—Anorexia—Methotrexate—multiple sclerosis	0.000639	0.000683	CcSEcCtD
Guanabenz—Rash—Methylprednisolone—multiple sclerosis	0.000638	0.000683	CcSEcCtD
Guanabenz—Dermatitis—Methylprednisolone—multiple sclerosis	0.000638	0.000682	CcSEcCtD
Guanabenz—Urticaria—Prednisone—multiple sclerosis	0.000637	0.000681	CcSEcCtD
Guanabenz—Headache—Triamcinolone—multiple sclerosis	0.000636	0.00068	CcSEcCtD
Guanabenz—Headache—Methylprednisolone—multiple sclerosis	0.000634	0.000679	CcSEcCtD
Guanabenz—Body temperature increased—Prednisone—multiple sclerosis	0.000634	0.000678	CcSEcCtD
Guanabenz—Abdominal pain—Prednisone—multiple sclerosis	0.000634	0.000678	CcSEcCtD
Guanabenz—Diarrhoea—Dexamethasone—multiple sclerosis	0.00063	0.000674	CcSEcCtD
Guanabenz—Diarrhoea—Betamethasone—multiple sclerosis	0.00063	0.000674	CcSEcCtD
Guanabenz—Hypotension—Methotrexate—multiple sclerosis	0.000626	0.00067	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000611	0.000653	CcSEcCtD
Guanabenz—Dizziness—Dexamethasone—multiple sclerosis	0.000609	0.000651	CcSEcCtD
Guanabenz—Dizziness—Betamethasone—multiple sclerosis	0.000609	0.000651	CcSEcCtD
Guanabenz—Nausea—Triamcinolone—multiple sclerosis	0.000603	0.000645	CcSEcCtD
Guanabenz—Paraesthesia—Methotrexate—multiple sclerosis	0.000602	0.000644	CcSEcCtD
Guanabenz—Nausea—Methylprednisolone—multiple sclerosis	0.000601	0.000643	CcSEcCtD
Guanabenz—Dyspnoea—Methotrexate—multiple sclerosis	0.000597	0.000639	CcSEcCtD
Guanabenz—Hypersensitivity—Prednisone—multiple sclerosis	0.000591	0.000632	CcSEcCtD
Guanabenz—Dyspepsia—Methotrexate—multiple sclerosis	0.00059	0.000631	CcSEcCtD
Guanabenz—Vomiting—Betamethasone—multiple sclerosis	0.000585	0.000626	CcSEcCtD
Guanabenz—Vomiting—Dexamethasone—multiple sclerosis	0.000585	0.000626	CcSEcCtD
Guanabenz—Decreased appetite—Methotrexate—multiple sclerosis	0.000583	0.000623	CcSEcCtD
Guanabenz—Rash—Dexamethasone—multiple sclerosis	0.000581	0.000621	CcSEcCtD
Guanabenz—Rash—Betamethasone—multiple sclerosis	0.000581	0.000621	CcSEcCtD
Guanabenz—Dermatitis—Betamethasone—multiple sclerosis	0.00058	0.000621	CcSEcCtD
Guanabenz—Dermatitis—Dexamethasone—multiple sclerosis	0.00058	0.000621	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000579	0.000619	CcSEcCtD
Guanabenz—Fatigue—Methotrexate—multiple sclerosis	0.000578	0.000618	CcSEcCtD
Guanabenz—Headache—Betamethasone—multiple sclerosis	0.000577	0.000617	CcSEcCtD
Guanabenz—Headache—Dexamethasone—multiple sclerosis	0.000577	0.000617	CcSEcCtD
Guanabenz—Asthenia—Prednisone—multiple sclerosis	0.000575	0.000615	CcSEcCtD
Guanabenz—Pain—Methotrexate—multiple sclerosis	0.000573	0.000613	CcSEcCtD
Guanabenz—Pruritus—Prednisone—multiple sclerosis	0.000567	0.000607	CcSEcCtD
Guanabenz—Feeling abnormal—Methotrexate—multiple sclerosis	0.000552	0.000591	CcSEcCtD
Guanabenz—Diarrhoea—Prednisone—multiple sclerosis	0.000549	0.000587	CcSEcCtD
Guanabenz—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000548	0.000586	CcSEcCtD
Guanabenz—Nausea—Betamethasone—multiple sclerosis	0.000547	0.000585	CcSEcCtD
Guanabenz—Nausea—Dexamethasone—multiple sclerosis	0.000547	0.000585	CcSEcCtD
Guanabenz—Urticaria—Methotrexate—multiple sclerosis	0.000532	0.00057	CcSEcCtD
Guanabenz—Dizziness—Prednisone—multiple sclerosis	0.00053	0.000567	CcSEcCtD
Guanabenz—Abdominal pain—Methotrexate—multiple sclerosis	0.00053	0.000567	CcSEcCtD
Guanabenz—Body temperature increased—Methotrexate—multiple sclerosis	0.00053	0.000567	CcSEcCtD
Guanabenz—Vomiting—Prednisone—multiple sclerosis	0.00051	0.000545	CcSEcCtD
Guanabenz—Rash—Prednisone—multiple sclerosis	0.000506	0.000541	CcSEcCtD
Guanabenz—Dermatitis—Prednisone—multiple sclerosis	0.000505	0.00054	CcSEcCtD
Guanabenz—Headache—Prednisone—multiple sclerosis	0.000502	0.000537	CcSEcCtD
Guanabenz—Hypersensitivity—Methotrexate—multiple sclerosis	0.000494	0.000528	CcSEcCtD
Guanabenz—Asthenia—Methotrexate—multiple sclerosis	0.000481	0.000514	CcSEcCtD
Guanabenz—Nausea—Prednisone—multiple sclerosis	0.000476	0.00051	CcSEcCtD
Guanabenz—Pruritus—Methotrexate—multiple sclerosis	0.000474	0.000507	CcSEcCtD
Guanabenz—Diarrhoea—Methotrexate—multiple sclerosis	0.000458	0.000491	CcSEcCtD
Guanabenz—Dizziness—Methotrexate—multiple sclerosis	0.000443	0.000474	CcSEcCtD
Guanabenz—Vomiting—Methotrexate—multiple sclerosis	0.000426	0.000456	CcSEcCtD
Guanabenz—Rash—Methotrexate—multiple sclerosis	0.000423	0.000452	CcSEcCtD
Guanabenz—Dermatitis—Methotrexate—multiple sclerosis	0.000422	0.000452	CcSEcCtD
Guanabenz—Headache—Methotrexate—multiple sclerosis	0.00042	0.000449	CcSEcCtD
Guanabenz—Nausea—Methotrexate—multiple sclerosis	0.000398	0.000426	CcSEcCtD
Guanabenz—ADRA2C—Signaling Pathways—TAGAP—multiple sclerosis	0.000107	0.00164	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR ligand binding—CCL5—multiple sclerosis	0.000105	0.00161	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000105	0.0016	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—CCR1—multiple sclerosis	0.000105	0.0016	CbGpPWpGaD
Guanabenz—ADRA2B—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000104	0.00159	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—GPR65—multiple sclerosis	0.000104	0.00159	CbGpPWpGaD
Guanabenz—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000102	0.00156	CbGpPWpGaD
Guanabenz—ADRA2B—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	0.000102	0.00156	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR ligand binding—CCR5—multiple sclerosis	0.000101	0.00155	CbGpPWpGaD
Guanabenz—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000101	0.00155	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—LINGO1—multiple sclerosis	0.0001	0.00154	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—S1PR1—multiple sclerosis	0.0001	0.00154	CbGpPWpGaD
Guanabenz—ADRA2A—G alpha (i) signalling events—POMC—multiple sclerosis	9.92e-05	0.00152	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—ITGA4—multiple sclerosis	9.92e-05	0.00152	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—CXCL10—multiple sclerosis	9.91e-05	0.00152	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—IFNB1—multiple sclerosis	9.85e-05	0.00151	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—GPC5—multiple sclerosis	9.76e-05	0.00149	CbGpPWpGaD
Guanabenz—ADRA2C—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	9.71e-05	0.00149	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CYP24A1—multiple sclerosis	9.68e-05	0.00148	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CYP27B1—multiple sclerosis	9.68e-05	0.00148	CbGpPWpGaD
Guanabenz—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	9.5e-05	0.00146	CbGpPWpGaD
Guanabenz—ADRA2A—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	9.5e-05	0.00146	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CCR1—multiple sclerosis	9.5e-05	0.00145	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CXCL13—multiple sclerosis	9.5e-05	0.00145	CbGpPWpGaD
Guanabenz—ADRA2C—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	9.49e-05	0.00145	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR ligand binding—CCR5—multiple sclerosis	9.47e-05	0.00145	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—PTGER4—multiple sclerosis	9.46e-05	0.00145	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—S1PR1—multiple sclerosis	9.37e-05	0.00144	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—CXCR3—multiple sclerosis	9.14e-05	0.0014	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—GPC5—multiple sclerosis	9.12e-05	0.0014	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—RRM1—multiple sclerosis	9.04e-05	0.00138	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—IL2RA—multiple sclerosis	8.93e-05	0.00137	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—CCL3—multiple sclerosis	8.92e-05	0.00137	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—CCR2—multiple sclerosis	8.89e-05	0.00136	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—GPC5—multiple sclerosis	8.86e-05	0.00136	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—PTGER4—multiple sclerosis	8.84e-05	0.00135	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TAGAP—multiple sclerosis	8.71e-05	0.00133	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—PTGER4—multiple sclerosis	8.59e-05	0.00132	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—CCL5—multiple sclerosis	8.53e-05	0.00131	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—CXCR3—multiple sclerosis	8.53e-05	0.00131	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—RGS1—multiple sclerosis	8.53e-05	0.00131	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—IL2RA—multiple sclerosis	8.34e-05	0.00128	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CCL3—multiple sclerosis	8.34e-05	0.00128	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—CCR2—multiple sclerosis	8.3e-05	0.00127	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—CXCR3—multiple sclerosis	8.3e-05	0.00127	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—CNR1—multiple sclerosis	8.2e-05	0.00126	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—GPR65—multiple sclerosis	8.09e-05	0.00124	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—CCR2—multiple sclerosis	8.07e-05	0.00124	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—PTGER4—multiple sclerosis	8.02e-05	0.00123	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—RGS1—multiple sclerosis	7.97e-05	0.00122	CbGpPWpGaD
Guanabenz—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	7.92e-05	0.00121	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR ligand binding—POMC—multiple sclerosis	7.92e-05	0.00121	CbGpPWpGaD
Guanabenz—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	7.89e-05	0.00121	CbGpPWpGaD
Guanabenz—ADRA2B—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	7.77e-05	0.00119	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CXCR3—multiple sclerosis	7.75e-05	0.00119	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR ligand binding—CCL2—multiple sclerosis	7.75e-05	0.00119	CbGpPWpGaD
Guanabenz—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	7.72e-05	0.00118	CbGpPWpGaD
Guanabenz—ADRA2A—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	7.71e-05	0.00118	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—CCR5—multiple sclerosis	7.69e-05	0.00118	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—CNR1—multiple sclerosis	7.66e-05	0.00117	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—S1PR1—multiple sclerosis	7.61e-05	0.00117	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SRM—multiple sclerosis	7.59e-05	0.00116	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—GPR65—multiple sclerosis	7.56e-05	0.00116	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CCR2—multiple sclerosis	7.54e-05	0.00115	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—CNR1—multiple sclerosis	7.45e-05	0.00114	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—GPC5—multiple sclerosis	7.41e-05	0.00113	CbGpPWpGaD
Guanabenz—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	7.4e-05	0.00113	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CXCL13—multiple sclerosis	7.4e-05	0.00113	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CCR1—multiple sclerosis	7.4e-05	0.00113	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR ligand binding—POMC—multiple sclerosis	7.4e-05	0.00113	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—CXCL10—multiple sclerosis	7.38e-05	0.00113	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—RRM1—multiple sclerosis	7.34e-05	0.00112	CbGpPWpGaD
Guanabenz—ADRA2C—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	7.26e-05	0.00111	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR ligand binding—CCL2—multiple sclerosis	7.24e-05	0.00111	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—PTGER4—multiple sclerosis	7.18e-05	0.0011	CbGpPWpGaD
Guanabenz—CYP1A2—Biological oxidations—POMC—multiple sclerosis	7.03e-05	0.00108	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CNR1—multiple sclerosis	6.96e-05	0.00107	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—CXCR3—multiple sclerosis	6.93e-05	0.00106	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CXCL13—multiple sclerosis	6.91e-05	0.00106	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CCR1—multiple sclerosis	6.91e-05	0.00106	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—CXCL10—multiple sclerosis	6.9e-05	0.00106	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—IL2RA—multiple sclerosis	6.78e-05	0.00104	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CCL3—multiple sclerosis	6.77e-05	0.00104	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—CCR2—multiple sclerosis	6.74e-05	0.00103	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—CXCL10—multiple sclerosis	6.71e-05	0.00103	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PTGER4—multiple sclerosis	6.52e-05	0.000998	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—RGS1—multiple sclerosis	6.47e-05	0.000991	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—ALB—multiple sclerosis	6.46e-05	0.000989	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—CCL5—multiple sclerosis	6.36e-05	0.000973	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CXCR3—multiple sclerosis	6.29e-05	0.000964	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CXCL10—multiple sclerosis	6.26e-05	0.000959	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—CNR1—multiple sclerosis	6.22e-05	0.000953	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—GPR65—multiple sclerosis	6.14e-05	0.00094	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CCR2—multiple sclerosis	6.12e-05	0.000937	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—ALB—multiple sclerosis	6.03e-05	0.000923	CbGpPWpGaD
Guanabenz—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	6.01e-05	0.00092	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—POMC—multiple sclerosis	6.01e-05	0.00092	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—CCL5—multiple sclerosis	5.94e-05	0.000909	CbGpPWpGaD
Guanabenz—ADRA2A—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	5.89e-05	0.000903	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—CCL2—multiple sclerosis	5.88e-05	0.0009	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—CCL5—multiple sclerosis	5.77e-05	0.000884	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—CCR5—multiple sclerosis	5.73e-05	0.000877	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CNR1—multiple sclerosis	5.65e-05	0.000865	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—IL2RA—multiple sclerosis	5.64e-05	0.000864	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CXCL13—multiple sclerosis	5.61e-05	0.000859	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCR1—multiple sclerosis	5.61e-05	0.000859	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—CXCL10—multiple sclerosis	5.6e-05	0.000858	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CCL5—multiple sclerosis	5.39e-05	0.000826	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—CCR5—multiple sclerosis	5.35e-05	0.000819	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	5.35e-05	0.000819	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	5.35e-05	0.000819	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—IL2RA—multiple sclerosis	5.27e-05	0.000807	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CCL3—multiple sclerosis	5.27e-05	0.000807	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—IL2—multiple sclerosis	5.24e-05	0.000802	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.22e-05	0.0008	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—CCR5—multiple sclerosis	5.2e-05	0.000796	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—BCHE—multiple sclerosis	5.19e-05	0.000795	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—IL2RA—multiple sclerosis	5.12e-05	0.000785	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CXCL10—multiple sclerosis	5.09e-05	0.000779	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PTGER4—multiple sclerosis	5.07e-05	0.000777	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PGR—multiple sclerosis	5e-05	0.000765	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CCL3—multiple sclerosis	4.92e-05	0.000754	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CXCR3—multiple sclerosis	4.9e-05	0.00075	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—ALB—multiple sclerosis	4.9e-05	0.00075	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—IL2—multiple sclerosis	4.89e-05	0.000749	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GPC5—multiple sclerosis	4.89e-05	0.000749	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CCR5—multiple sclerosis	4.86e-05	0.000744	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CD28—multiple sclerosis	4.85e-05	0.000743	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—CCL5—multiple sclerosis	4.82e-05	0.000738	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—IL2RA—multiple sclerosis	4.79e-05	0.000733	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CCR2—multiple sclerosis	4.77e-05	0.00073	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PTGER4—multiple sclerosis	4.74e-05	0.000726	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PGR—multiple sclerosis	4.67e-05	0.000715	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CXCR3—multiple sclerosis	4.58e-05	0.000701	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CD28—multiple sclerosis	4.53e-05	0.000694	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—POMC—multiple sclerosis	4.48e-05	0.000685	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CCR2—multiple sclerosis	4.45e-05	0.000682	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CNR1—multiple sclerosis	4.4e-05	0.000674	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CCL5—multiple sclerosis	4.38e-05	0.000671	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—CCR5—multiple sclerosis	4.34e-05	0.000665	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—IL2RA—multiple sclerosis	4.28e-05	0.000656	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—BCHE—multiple sclerosis	4.22e-05	0.000645	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—POMC—multiple sclerosis	4.18e-05	0.00064	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CNR1—multiple sclerosis	4.11e-05	0.000629	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—TGFB1—multiple sclerosis	4.08e-05	0.000625	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—POMC—multiple sclerosis	4.06e-05	0.000622	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—RRM1—multiple sclerosis	4.05e-05	0.00062	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—MAPK1—multiple sclerosis	4e-05	0.000613	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCL3—multiple sclerosis	4e-05	0.000612	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—CCL2—multiple sclerosis	3.98e-05	0.000609	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—IL2—multiple sclerosis	3.97e-05	0.000608	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CXCL10—multiple sclerosis	3.96e-05	0.000606	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CCR5—multiple sclerosis	3.95e-05	0.000604	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—IL2RA—multiple sclerosis	3.89e-05	0.000595	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PTGER4—multiple sclerosis	3.85e-05	0.000589	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—TGFB1—multiple sclerosis	3.81e-05	0.000584	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—POMC—multiple sclerosis	3.8e-05	0.000581	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PGR—multiple sclerosis	3.79e-05	0.00058	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—MAPK1—multiple sclerosis	3.74e-05	0.000573	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CXCR3—multiple sclerosis	3.72e-05	0.000569	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CCL2—multiple sclerosis	3.71e-05	0.000569	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CXCL10—multiple sclerosis	3.7e-05	0.000567	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CD28—multiple sclerosis	3.68e-05	0.000564	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCR2—multiple sclerosis	3.62e-05	0.000554	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—TYK2—multiple sclerosis	3.61e-05	0.000553	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CD86—multiple sclerosis	3.46e-05	0.00053	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CCL5—multiple sclerosis	3.41e-05	0.000522	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—POMC—multiple sclerosis	3.4e-05	0.00052	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—TYK2—multiple sclerosis	3.37e-05	0.000516	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CNR1—multiple sclerosis	3.34e-05	0.000511	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—IL2—multiple sclerosis	3.31e-05	0.000507	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CD86—multiple sclerosis	3.24e-05	0.000495	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CCL5—multiple sclerosis	3.19e-05	0.000488	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—SPP1—multiple sclerosis	3.16e-05	0.000483	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.14e-05	0.000481	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—APOE—multiple sclerosis	3.12e-05	0.000478	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—TGFB1—multiple sclerosis	3.1e-05	0.000474	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—IL2—multiple sclerosis	3.09e-05	0.000473	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—POMC—multiple sclerosis	3.08e-05	0.000472	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CCR5—multiple sclerosis	3.07e-05	0.00047	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—MAPK1—multiple sclerosis	3.04e-05	0.000465	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IL2RA—multiple sclerosis	3.03e-05	0.000464	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CCL2—multiple sclerosis	3.02e-05	0.000462	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CXCL10—multiple sclerosis	3.01e-05	0.00046	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—IL2—multiple sclerosis	3e-05	0.00046	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—SPP1—multiple sclerosis	2.95e-05	0.000452	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CCR5—multiple sclerosis	2.87e-05	0.000439	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IL2RA—multiple sclerosis	2.83e-05	0.000433	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—IL2—multiple sclerosis	2.81e-05	0.00043	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—APOE—multiple sclerosis	2.79e-05	0.000428	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	2.74e-05	0.000419	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.7e-05	0.000413	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—POMC—multiple sclerosis	2.68e-05	0.000411	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	2.63e-05	0.000402	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—APOE—multiple sclerosis	2.61e-05	0.0004	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	2.59e-05	0.000396	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—APOE—multiple sclerosis	2.54e-05	0.000388	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CD80—multiple sclerosis	2.53e-05	0.000387	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	2.51e-05	0.000384	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.46e-05	0.000377	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—ALB—multiple sclerosis	2.45e-05	0.000374	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	2.4e-05	0.000368	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	2.4e-05	0.000367	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CD80—multiple sclerosis	2.36e-05	0.000361	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	2.35e-05	0.00036	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	2.33e-05	0.000357	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—BCHE—multiple sclerosis	2.33e-05	0.000356	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	2.3e-05	0.000352	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	2.3e-05	0.000352	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	2.28e-05	0.000349	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—POMC—multiple sclerosis	2.24e-05	0.000343	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CCL2—multiple sclerosis	2.19e-05	0.000336	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—POMC—multiple sclerosis	2.18e-05	0.000334	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—MAPK1—multiple sclerosis	2.15e-05	0.000329	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	2.13e-05	0.000327	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	2.12e-05	0.000325	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TYK2—multiple sclerosis	1.99e-05	0.000305	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—ALB—multiple sclerosis	1.99e-05	0.000304	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	1.92e-05	0.000294	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	1.82e-05	0.000279	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	1.78e-05	0.000273	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	1.77e-05	0.000272	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	1.77e-05	0.00027	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	1.74e-05	0.000267	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	1.68e-05	0.000257	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IL2—multiple sclerosis	1.66e-05	0.000254	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—IL6—multiple sclerosis	1.65e-05	0.000253	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	1.62e-05	0.000248	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MMP9—multiple sclerosis	1.57e-05	0.00024	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	1.49e-05	0.000229	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOE—multiple sclerosis	1.4e-05	0.000214	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—STAT3—multiple sclerosis	1.4e-05	0.000214	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	1.39e-05	0.000212	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	1.38e-05	0.000212	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	1.36e-05	0.000208	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	1.35e-05	0.000206	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	1.34e-05	0.000205	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MYC—multiple sclerosis	1.3e-05	0.000198	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TGFB1—multiple sclerosis	1.29e-05	0.000198	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	1.27e-05	0.000195	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MAPK1—multiple sclerosis	1.27e-05	0.000194	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—POMC—multiple sclerosis	1.2e-05	0.000184	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	1.13e-05	0.000174	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ALB—multiple sclerosis	1.1e-05	0.000168	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	1.05e-05	0.000161	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	1.05e-05	0.000161	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	1.04e-05	0.00016	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	1.03e-05	0.000158	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IL6—multiple sclerosis	9.74e-06	0.000149	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	7.92e-06	0.000121	CbGpPWpGaD
